TY - JOUR
T1 - Defining mitochondrial protein functions through deep multiomic profiling
AU - Rensvold, Jarred W.
AU - Shishkova, Evgenia
AU - Sverchkov, Yuriy
AU - Miller, Ian J.
AU - Cetinkaya, Arda
AU - Pyle, Angela
AU - Manicki, Mateusz
AU - Brademan, Dain R.
AU - Alanay, Yasemin
AU - Raiman, Julian
AU - Jochem, Adam
AU - Hutchins, Paul D.
AU - Peters, Sean R.
AU - Linke, Vanessa
AU - Overmyer, Katherine A.
AU - Salome, Austin Z.
AU - Hebert, Alexander S.
AU - Vincent, Catherine E.
AU - Kwiecien, Nicholas W.
AU - Rush, Matthew J.P.
AU - Westphall, Michael S.
AU - Craven, Mark
AU - Akarsu, Nurten A.
AU - Taylor, Robert W.
AU - Coon, Joshua J.
AU - Pagliarini, David J.
N1 - Funding Information:
We thank J. Stefely for suggestions on experimental design, B. Floyd and N. Niemi for advice on knockout target selection, M. McDevitt and J. Stefely for guidance on lipid extraction, Z. Baker for data observations and A. Bartlett, M. Stefely, A. Sung and S. Hwang for graphic contributions. We thank Y. Murakami and T. Kinoshita (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for providing the pRL-CMV-PreYF-PIG-YF expression constructs, J. Fan for advice on metabolite extraction and Y. Sancak for advice on cellular calcium analysis. This work was supported by NIH awards R35 GM131795 (D.J.P.), P41 GM108538 (J.J.C. and D.J.P.) and U54 AI117924 (Y.S. and M.C.); a UW2020 award (D.J.P. and J.J.C.); funds from the BJC Investigator Program (D.J.P.); and a grant from the Scientific and Technological Research Council of Turkey, 108S420 (N.A.A.) under the framework of ERA-NET for Research on Rare Disease, CRANIRARE Consortium (R07197KS). R.W.T. was supported by the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust, the Mitochondrial Disease Patient Cohort (UK) (G0800674), the Lily Foundation, the Pathological Society and the NHS Highly Specialised Service for Rare Mitochondrial Disorders.
Funding Information:
We thank J. Stefely for suggestions on experimental design, B. Floyd and N. Niemi for advice on knockout target selection, M. McDevitt and J. Stefely for guidance on lipid extraction, Z. Baker for data observations and A. Bartlett, M. Stefely, A. Sung and S. Hwang for graphic contributions. We thank Y. Murakami and T. Kinoshita (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for providing the pRL-CMV-PreYF-PIG-YF expression constructs, J. Fan for advice on metabolite extraction and Y. Sancak for advice on cellular calcium analysis. This work was supported by NIH awards R35 GM131795 (D.J.P.), P41 GM108538 (J.J.C. and D.J.P.) and U54 AI117924 (Y.S. and M.C.); a UW2020 award (D.J.P. and J.J.C.); funds from the BJC Investigator Program (D.J.P.); and a grant from the Scientific and Technological Research Council of Turkey, 108S420 (N.A.A.) under the framework of ERA-NET for Research on Rare Disease, CRANIRARE Consortium (R07197KS). R.W.T. was supported by the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust, the Mitochondrial Disease Patient Cohort (UK) (G0800674), the Lily Foundation, the Pathological Society and the NHS Highly Specialised Service for Rare Mitochondrial Disorders.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/6/9
Y1 - 2022/6/9
N2 - Mitochondria are epicentres of eukaryotic metabolism and bioenergetics. Pioneering efforts in recent decades have established the core protein componentry of these organelles1 and have linked their dysfunction to more than 150 distinct disorders2,3. Still, hundreds of mitochondrial proteins lack clear functions4, and the underlying genetic basis for approximately 40% of mitochondrial disorders remains unresolved5. Here, to establish a more complete functional compendium of human mitochondrial proteins, we profiled more than 200 CRISPR-mediated HAP1 cell knockout lines using mass spectrometry-based multiomics analyses. This effort generated approximately 8.3 million distinct biomolecule measurements, providing a deep survey of the cellular responses to mitochondrial perturbations and laying a foundation for mechanistic investigations into protein function. Guided by these data, we discovered that PIGY upstream open reading frame (PYURF) is an S-adenosylmethionine-dependent methyltransferase chaperone that supports both complex I assembly and coenzyme Q biosynthesis and is disrupted in a previously unresolved multisystemic mitochondrial disorder. We further linked the putative zinc transporter SLC30A9 to mitochondrial ribosomes and OxPhos integrity and established RAB5IF as the second gene harbouring pathogenic variants that cause cerebrofaciothoracic dysplasia. Our data, which can be explored through the interactive online MITOMICS.app resource, suggest biological roles for many other orphan mitochondrial proteins that still lack robust functional characterization and define a rich cell signature of mitochondrial dysfunction that can support the genetic diagnosis of mitochondrial diseases.
AB - Mitochondria are epicentres of eukaryotic metabolism and bioenergetics. Pioneering efforts in recent decades have established the core protein componentry of these organelles1 and have linked their dysfunction to more than 150 distinct disorders2,3. Still, hundreds of mitochondrial proteins lack clear functions4, and the underlying genetic basis for approximately 40% of mitochondrial disorders remains unresolved5. Here, to establish a more complete functional compendium of human mitochondrial proteins, we profiled more than 200 CRISPR-mediated HAP1 cell knockout lines using mass spectrometry-based multiomics analyses. This effort generated approximately 8.3 million distinct biomolecule measurements, providing a deep survey of the cellular responses to mitochondrial perturbations and laying a foundation for mechanistic investigations into protein function. Guided by these data, we discovered that PIGY upstream open reading frame (PYURF) is an S-adenosylmethionine-dependent methyltransferase chaperone that supports both complex I assembly and coenzyme Q biosynthesis and is disrupted in a previously unresolved multisystemic mitochondrial disorder. We further linked the putative zinc transporter SLC30A9 to mitochondrial ribosomes and OxPhos integrity and established RAB5IF as the second gene harbouring pathogenic variants that cause cerebrofaciothoracic dysplasia. Our data, which can be explored through the interactive online MITOMICS.app resource, suggest biological roles for many other orphan mitochondrial proteins that still lack robust functional characterization and define a rich cell signature of mitochondrial dysfunction that can support the genetic diagnosis of mitochondrial diseases.
UR - http://www.scopus.com/inward/record.url?scp=85130710339&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-04765-3
DO - 10.1038/s41586-022-04765-3
M3 - Article
C2 - 35614220
AN - SCOPUS:85130710339
SN - 0028-0836
VL - 606
SP - 382
EP - 388
JO - Nature
JF - Nature
IS - 7913
ER -